A novel cyclic γ-AApeptide-based long-acting pan-coronavirus fusion inhibitor with potential oral bioavailability by targeting two sites in spike protein.
Xue S, Wang X, Wang L, Xu W, Xia S, Sun L, Wang S, Shen N, Yang Z, Huang B, Li S, Cao C, Calcul L, Sun X, Lu L, Cai J, Jiang S.
Xue S, et al. Among authors: wang x, wang l, wang s.
Cell Discov. 2022 Sep 8;8(1):88. doi: 10.1038/s41421-022-00455-6.
Cell Discov. 2022.
PMID: 36075899
Free PMC article.